Market Overview

Benzinga's Top Pre-Market Losers

Share:
Related JCP
How Store Counts Of America's Biggest Retailers Changed Since 2007
Watch These 10 Huge Call Purchases In Thursday Trade
Notable earnings before Friday's open (Seeking Alpha)
Related NKTR
Benzinga's Option Alert Recap From January 23
Why The Last Week Of 2016 Could Be Big For Biotech Catalysts

Nektar Therapeutics (NASDAQ: NKTR) dipped 24.19% to $10.50 in the pre-market session after the company reported that the results from Phase 2 trial of NKTR-181 missed primary efficacy endpoint.

Zoltek Companies (NASDAQ: ZOLT) shares dropped 10.05% to $16.65 in pre-market trading after Toray Industries agreed to buy Zoltek Companies for $16.75 per share.

J. C. Penney Company (NYSE: JCP) shares fell 8.54% to $9.53 in the pre-market trading after the company priced its underwritten public offering of 84.0 million shares of its common stock at $9.65 per share.

Accenture (NYSE: ACN) dipped 4.18% to $72.70 in the pre-market session after the company reported a rise in its fiscal fourth-quarter net income. For the current fiscal year, the company projected net income of $4.42 to $4.54 per share, versus analysts' expectations of $4.50 per share.

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets

 

Related Articles (ACN + JCP)

View Comments and Join the Discussion!